Comparative bibliometric analysis of highly cited monkeypox research in general and specialized infectious disease journals: Dissecting trends, collaborations, and impact

IF 4.7 3区医学 Q1 INFECTIOUS DISEASES

Journal of Infection and Public Health Pub Date : 2025-04-10 DOI:10.1016/j.jiph.2025.102769

Rui-Xuan Li , Zhi-Xin Li , Yu-Yue Shen , Jia-Jie Guo , Yue Liu , Jia-Yu Cai , Bin-Bin Xiang , Xin-Rong Ye , Xu-Guang Guo

{"title":"Comparative bibliometric analysis of highly cited monkeypox research in general and specialized infectious disease journals: Dissecting trends, collaborations, and impact","authors":"Rui-Xuan Li , Zhi-Xin Li , Yu-Yue Shen , Jia-Jie Guo , Yue Liu , Jia-Yu Cai , Bin-Bin Xiang , Xin-Rong Ye , Xu-Guang Guo","doi":"10.1016/j.jiph.2025.102769","DOIUrl":null,"url":null,"abstract":"<div><div>This study employs bibliometric methods to analyze global publication trends in monkeypox (MPX) research from 2022 to 2024. Using the Web of Science Core Collection database, we identified the top 100 cited articles from all journals and infectious disease specialty journals. The United States and the United Kingdom were the most productive countries, with significant contributions from African nations like Nigeria. Key institutions included the Centers for Disease Control and Prevention (CDC) and the University of London. Research focused on virus transmission, clinical manifestations, and treatments, especially vaccines and antiviral strategies after MPX was declared a Public Health Emergency of International Concern (PHEIC). Our findings offer micro-level insights into biological mechanisms and targeted therapies, as well as macro-level perspectives on international collaboration and policy impact. These results are essential for guiding future diagnostic, therapeutic, and preventive strategies.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"18 7","pages":"Article 102769"},"PeriodicalIF":4.7000,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Public Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1876034125001182","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

Abstract

This study employs bibliometric methods to analyze global publication trends in monkeypox (MPX) research from 2022 to 2024. Using the Web of Science Core Collection database, we identified the top 100 cited articles from all journals and infectious disease specialty journals. The United States and the United Kingdom were the most productive countries, with significant contributions from African nations like Nigeria. Key institutions included the Centers for Disease Control and Prevention (CDC) and the University of London. Research focused on virus transmission, clinical manifestations, and treatments, especially vaccines and antiviral strategies after MPX was declared a Public Health Emergency of International Concern (PHEIC). Our findings offer micro-level insights into biological mechanisms and targeted therapies, as well as macro-level perspectives on international collaboration and policy impact. These results are essential for guiding future diagnostic, therapeutic, and preventive strategies.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Infection and Public Health PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH -INFECTIOUS DISEASES

CiteScore

13.10

自引率

1.50%

发文量

203

审稿时长

96 days

期刊介绍： The Journal of Infection and Public Health, first official journal of the Saudi Arabian Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and the Saudi Association for Public Health, aims to be the foremost scientific, peer-reviewed journal encompassing infection prevention and control, microbiology, infectious diseases, public health and the application of healthcare epidemiology to the evaluation of health outcomes. The point of view of the journal is that infection and public health are closely intertwined and that advances in one area will have positive consequences on the other. The journal will be useful to all health professionals who are partners in the management of patients with communicable diseases, keeping them up to date. The journal is proud to have an international and diverse editorial board that will assist and facilitate the publication of articles that reflect a global view on infection control and public health, as well as emphasizing our focus on supporting the needs of public health practitioners. It is our aim to improve healthcare by reducing risk of infection and related adverse outcomes by critical review, selection, and dissemination of new and relevant information in the field of infection control, public health and infectious diseases in all healthcare settings and the community.